معرفی
Susan B. Olson is a Professor in the Department of Medical Genetics at Oregon Health & Science University's School of Medicine. With over three decades of experience since earning her Ph.D. in Medical Genetics in 1987, she has established herself as a leading researcher in cytogenetics and molecular genetics, particularly focusing on Fanconi anemia and hematologic malignancies. Her work bridges basic science with clinical applications, contributing significantly to our understanding of genetic disorders and cancer mechanisms.
Dr. Olson's research interests center on the molecular mechanisms of Fanconi anemia, acute myeloid leukemia, and other genetic disorders. Her laboratory investigates DNA repair pathways, particularly the Fanconi anemia pathway, and how defects in these processes lead to bone marrow failure and cancer predisposition. She has made significant contributions to understanding NUP98 rearrangements in leukemia, RUNX1 mutations, and the role of FANCD2 in DNA replication through fragile sites. Her work often combines cytogenetic analysis with molecular techniques to uncover novel mechanisms underlying genetic diseases.
Analysis of Dr. Olson's recent publications (2016-2024) reveals a consistent focus on genetic mechanisms in cancer and inherited disorders. Her research spans from basic molecular studies of DNA repair mechanisms to clinical investigations of leukemia and lymphoma. A significant portion of her work centers on Fanconi anemia pathophysiology, with applications to understanding cancer development. She frequently employs advanced techniques including single-cell and spatial transcriptomics, cytogenetic analysis, and molecular diagnostics to address fundamental questions in medical genetics.
Throughout her career, Dr. Olson has maintained productive collaborations with clinicians and researchers across multiple institutions, particularly with Stephen R. Moore at Oregon Health & Science University. Her work has been supported by various research grants focused on understanding the molecular basis of genetic disorders and developing potential therapeutic approaches, particularly for Fanconi anemia and acute myeloid leukemia.
